Prevalence of eosinophilia in hospitalized patients with asthma exacerbation

Respiratory Medicine

Volumn 109, Issue 9, 2015, Pages 1230-1232

  Hasegawa, Kohei ^a   Stoll, Samantha J ^a,b   Ahn, Jason ^a,b   Bittner, Jane C ^a   Camargo, Carlos A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute asthma; Asthma phenotypes; Biologic therapies; Eosinophilia; Hospitalization; Prevalence

Indexed keywords

CORTICOSTEROID; ANTIASTHMATIC AGENT;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; CLINICAL TRIAL; COMPLICATION; MASSACHUSETTS; MULTICENTER STUDY; YOUNG ADULT;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; EOSINOPHILIA; FEMALE; HOSPITALIZATION; HUMANS; MALE; MASSACHUSETTS; PILOT PROJECTS; PREVALENCE; YOUNG ADULT;

EID: 84941744814     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.07.011     Document Type: Article

References (17)

1. Trends in Asthma Morbidity and Mortality 2012 American Lung Assoication [Cited 2015 July 1] Available from: http://www.lung.org/finding-cures/our-research/epidemiology-and-statistics-rpts.html
2. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, R.A. Pauwels, and et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study Am. J. Respir. Crit. Care Med. 170 2004 836 844
3. S.E. Wenzel Asthma phenotypes: the evolution from clinical to molecular approaches Nat. Med. 18 2012 716 725
4. W. Wu, E. Bleecker, W. Moore, W.W. Busse, M. Castro, K.F. Chung, and et al. Unsupervised phenotyping of severe asthma research program participants using expanded lung data J. Allergy Clin. Immunol. 133 2014 1280 1288
5. C. Miranda, A. Busacker, S. Balzar, J. Trudeau, and S.E. Wenzel Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation J. Allergy Clin. Immunol. 113 2004 101 108
6. M. Amelink, J.C. de Groot, S.B. de Nijs, R. Lutter, A.H. Zwinderman, P.J. Sterk, and et al. Severe adult-onset asthma: a distinct phenotype J. Allergy Clin. Immunol. 132 2013 336 341
7. P. Haldar, I.D. Pavord, D.E. Shaw, M.A. Berry, M. Thomas, C.E. Brightling, and et al. Cluster analysis and clinical asthma phenotypes Am. J. Respir. Crit. Care Med. 178 2008 218 224
8. H.G. Ortega, M.C. Liu, I.D. Pavord, G.G. Brusselle, J.M. FitzGerald, A. Chetta, and et al. Mepolizumab treatment in patients with severe eosinophilic asthma N. Engl. J. Med. 371 2014 1198 1207
9. E.H. Bel, S.E. Wenzel, P.J. Thompson, C.M. Prazma, O.N. Keene, S.W. Yancey, and et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma N. Engl. J. Med. 371 2014 1189 1197
10. I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, O.N. Keene, and et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Lancet 380 2012 651 659
11. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, and et al. Dupilumab in persistent asthma with elevated eosinophil levels N. Engl. J. Med. 368 2013 2455 2466
12. P. Nair What is an "eosinophilic phenotype" of asthma? J. Allergy Clin. Immunol. 132 2013 81 83
13. K. Hasegawa, J.C. Bittner, S.A. Nonas, S.J. Stoll, T. Watase, S. Gabriel, and et al. Children and adults with frequent hospitalizations for asthma exacerbation, 2012-2013: a multicenter observational study J. Allergy Clin. Immunol. In. Pract. 2015 [epub ahead of print]
14. K. Hasegawa, J. Ahn, M.A. Brown, V.G. Press, S. Gabriel, V. Herrera, and et al. Underutilization of guideline-recommended chronic asthma management in children hospitalized to the intensive care unit: a multicenter observational study Ann. Allergy Asthma Immunol. 115 2015 10 16
15. HCUPnet. U.S. Department of Health and Human Services. Agency For Healthcare Research and Quality. [Cited 2015 July 31]. Available from: http://hcupnet.ahrq.gov/.
16. M. Schatz, L.M. Meckley, M. Kim, B.T. Stockwell, and M. Castro Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy J. Allergy Clin. Immunol. Pract. 2 2014 570-574 e1
17. K. Hasegawa, T. Chiba, Y. Hagiwara, H. Watase, Y. Tsugawa, D.F. Brown, and et al. Quality of care for acute asthma in emergency departments in Japan: a multicenter observational study J. Allergy Clin. Immunol. Pract. 1 2013 509 515